In those experiments, pretreatment with the peptide enhanced subsequent responses to growth hormone stimulation, including increased cell viability, elevated proliferating cell nuclear antigen (PCNA) expression, and greater JAK2 phosphorylation activity [5]
For injectable products, extra attention to strength, route, storage, and supplies helps prevent avoidable order errors
Remaining in vial: approximately 9mg
FDA's 2024 review states the mechanism of action is still unknown, which limits how confidently any specific physiological effect can be predicted in humans
In cases of severe deficiency or pernicious anemia, injections may be given daily or weekly initially, followed by maintenance doses every month
It is not intended as a human pharmaceutical diluent in clinical contexts.